For-profit organizations · Burnaby, British Columbia
Qu Biologics Inc.
- Total value
- $9.2M
- Agreements
- 14
- Programs
- 3
- First and latest
- 2009–2024
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
Applying for the same funding? NRC IRAP Financial Assistance (apply through the funder’s page; no deadline stated). Deadlines, who can apply and who else got it.
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 5 | $8.2M |
| Industrial Research Assistance Program – Innovation Assistance Program | National Research Council Canada | 2 | $123K |
| Innovation Assistance Program | National Research Council Canada | 1 | $71K |
Plus 6 agreements ($850K) where the department did not name a program.
By year
Funding by the year agreements started.
Show the numbers
| Year | Agreements | Total |
|---|---|---|
| 2009 | 3 | $476K |
| 2010 | 1 | $30K |
| 2011 | 0 | $0 |
| 2012 | 1 | $300K |
| 2013 | 0 | $0 |
| 2014 | 1 | $44K |
| 2015 | 0 | $0 |
| 2016 | 0 | $0 |
| 2017 | 0 | $0 |
| 2018 | 0 | $0 |
| 2019 | 1 | $154K |
| 2020 | 5 | $3M |
| 2021 | 0 | $0 |
| 2022 | 1 | $5.2M |
| 2023 | 0 | $0 |
| 2024 | 1 | $12K |
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| May 2024 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | IP Assist: Intellectual Property Strategy EngagementContribution | $11,642 |
| Sep 2022 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Rapid Response: Assessment of the Effect of lung-directed Site-Specific Immunomodulator (SSI) in clinical trial QBKPN-CV-01: Assessment of the Effect of QBKPN Site-Specific Immunomodulator (SSI) on Innate Immunity and COVID-19 VaccContribution | $5,176,172 |
| Dec 2020 | Industrial Research Assistance Program – Innovation Assistance ProgramNational Research Council Canada | Innovation Assistance Program – Round 2.5Contribution | $37,933 |
| Dec 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Rapid Response: Preclinical studies for safety and efficacy of lung-directed Site-Specific Immunomodulator (SSI) in COVID-19 relevant animal modelContribution | $2,780,109 |
| Aug 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Rapid Response: Novel Immune Therapeutic for the Prevention and Treatment of COVID-19Contribution | $38,170 |
| Jun 2020 | Industrial Research Assistance Program – Innovation Assistance ProgramNational Research Council Canada | Innovation Assistance Program - Round 2Contribution | $85,232 |
| Apr 2020 | Innovation Assistance ProgramNational Research Council Canada | Innovation Assistance ProgramContribution | $71,148 |
| Mar 2019 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Enhancing eradication of solid tumours using Site-Specific Immunomodulators and engineered cancer-specific T cellsContribution | $153,855 |
| Sep 2014 | Program not namedNational Research Council Canada | Contribution | $44,129 |
| May 2012 | Program not namedNational Research Council Canada | Contribution | $300,000 |
| May 2010 | Program not namedNational Research Council Canada | Contribution | $30,000 |
| Jul 2009 | Program not namedNational Research Council Canada | Contribution | $214,948 |
| Jul 2009 | Program not namedNational Research Council Canada | Contribution | $187,948 |
| Jul 2009 | Program not namedNational Research Council Canada | Contribution | $72,865 |